Abstract
Abstract
Purpose of Review
There is a paucity of peer-reviewed evidence to guide medical management of stuttering priapism. The purpose of this review is to summarize the current understanding regarding the pathophysiology of priapism and management options for stuttering priapism.
Recent Findings
Conducting large-scale, randomized, placebo-controlled trials that elucidate the optimal treatment of stuttering priapism is challenging. Therefore, recent treatment guidelines are based upon small case series, retrospective studies, and expert opinions. Nonetheless, multiple compounds from various drug classes have shown promise in treating stuttering priapism, and a few pharmacotherapies such as Crizanlizumab are currently under active investigation.
Summary
Stuttering priapism is an under-investigated disorder with a complex pathophysiology. Currently, there is no wildly adopted universal therapeutic strategy. Further research is warranted to identify the appropriate treatment of stuttering priapism and to determine the long-term side effects of current pharmacotherapies.
Publisher
Springer Science and Business Media LLC
Subject
Urology,Obstetrics and Gynecology
Reference99 articles.
1. •• Bivalacqua TJ, Allen BK, Brock GB, et al. The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA/SMSNA guideline. J Urol. 2022;208(1):43–52. https://doi.org/10.1097/JU.0000000000002767.T. (The most recent guideline by the AUA for the treatment of priapism including the stuttering subtype.)
2. Abdeen BM, Leslie SW. Stuttering Priapism. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. [Updated 2022 May 27]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK574517/?report=classic
3. Silberman M, Stormont G, Leslie SW, et al. Priapism. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. [Updated 2022 Jul 17]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459178/
4. Sui W, Onyeji IC, James MB, Stahl PJ, RoyChoudhury A, Anderson CB. Risk factors for priapism readmission. J Sex Med. 2016;13(10):1555–61. https://doi.org/10.1016/j.jsxm.2016.07.009.
5. Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med. 1980;140(11):1434–7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献